Video

Can you summarize the epidemiology, evaluation, quality-of-life issues, and treatment challenges for hypothyroidism encountered by clinicians, including primary care, internal medicine, endocrine, women’s health, and geriatric specialists?

Can you summarize the epidemiology, evaluation, quality-of-life issues, and treatment challenges for hypothyroidism encountered by clinicians, including primary care, internal medicine, endocrine, women’s health, and geriatric specialists?

Video

What exactly is the composition of DTE, how does it differ from montherapeutic agents used to treat hypothyroidism, and what is its currently regulatory status?

What exactly is the composition of DTE, how does it differ from montherapeutic agents used to treat hypothyroidism, and what is its currently regulatory status?

Video

Can you discuss in detail what questions appear on the questionnaire you use to evaluate the success of thyroid hormone replacement therapy and whether, based on these results, a trial of combination therapy with DTE is warranted?

Can you discuss in detail what questions appear on the questionnaire you use to evaluate the success of thyroid hormone replacement therapy and whether, based on these results, a trial of combination therapy with DTE is warranted?

Video

Can you please let us know a little bit about yourself, including your previous affiliations and experience treating patients with thyroid disease, especially hypothyroidism?

Can you please let us know a little bit about yourself, including your previous affiliations and experience treating patients with thyroid disease, especially hypothyroidism?

Video

Once you’ve started a patient on T4 monotherapy, how do you monitor the patient, with a focus on (a) laboratory parameters of thyroid function and (b) judging whether or not you’ve achieved an acceptable or, even, optimal, clinical response to initial treatment?

Once you’ve started a patient on T4 monotherapy, how do you monitor the patient, with a focus on (a) laboratory parameters of thyroid function and (b) judging whether or not you’ve achieved an acceptable or, even, optimal, clinical response ...

Video

Once you or any clinician has determined that DTE may be an appropriate treatment approach for a patient with hypothyroidism, how do you transition the patient from T4 to DTE, and what should the thyroid function monitoring strategy be for patients who have been started on DTE?

Once you or any clinician has determined that DTE may be an appropriate treatment approach for a patient with hypothyroidism, how do you transition the patient from T4 to DTE, and what should the thyroid function monitoring strategy be ...

Video

In light of positive clinical studies, how do you navigate the clinical decision tree in which you have to identify persons with hypothyroidism who are not meeting all your clinical objectives on T4 monotherapy and who may be candidates for DTE?

In light of positive clinical studies, how do you navigate the clinical decision tree in which you have to identify persons with hypothyroidism who are not meeting all your clinical objectives on T4 monotherapy and who may be candidates for DTE?

Video

Based on the North Star trial what should the starting dose of DTE be and how should the patient be monitored?

Based on the North Star trial what should the starting dose of DTE be and how should the patient be monitored?

Video

Can you please let us know a little bit about yourself, including your previous affiliations and experience at the Uniformed Services University of the Health Sciences treating patients with thyroid disease, especially hypothyroidism?

Can you please let us know a little bit about yourself, including your previous affiliations and experience at the Uniformed Services University of the Health Sciences treating patients with thyroid disease, especially hypothyroidism?